Home
LXEO
LXEO News

Latest Lexeo Therapeutics Inc. (LXEO) News on July 31, 2025

MT Newswires

a month ago

Lexeo Therapeutics Partners with PXV Funds, venBio on New Cardiac RNA Therapeutics Venture

Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA Therapeutics

GlobeNewswire

a month ago

Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA Therapeutics

MT Newswires

2 months ago

Lexeo Therapeutics Registers Share Offering on Behalf of Selling Stockholders

June 2025 Penny Stocks With Promising Potential

Simply Wall St.

2 months ago

June 2025 Penny Stocks With Promising Potential

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases

GlobeNewswire

2 months ago

Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases

MT Newswires

3 months ago

Chardan Adjusts Price Target on Lexeo Therapeutics to $20 From $22, Maintains Buy Rating

Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights

GlobeNewswire

3 months ago

Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights

Undervalued Penny Stocks To Consider In May 2025

Simply Wall St.

3 months ago

Undervalued Penny Stocks To Consider In May 2025

Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

GlobeNewswire

3 months ago

Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

MT Newswires

4 months ago

Chardan Research Adjusts Lexeo Therapeutics Price Target to $22 From $25, Maintains Buy Rating

MT Newswires

4 months ago

Lexeo Therapeutics Says Potential FA Cardiomyopathy Therapy Improves Cardiac Biomarkers

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

GlobeNewswire

4 months ago

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

Why Lexeo Therapeutics (LXEO) Skyrocketed on Monday?

Insider Monkey

4 months ago

Why Lexeo Therapeutics (LXEO) Skyrocketed on Monday?

MT Newswires

4 months ago

RBC Cuts Price Target on Lexeo Therapeutics to $20 From $24, Keeps Outperform, Speculative Risk

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

GlobeNewswire

4 months ago

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MT Newswires

7 months ago

Lexeo Therapeutics Appoints Kyle Rasbach as CFO

Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer

GlobeNewswire

7 months ago

Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer

MT Newswires

8 months ago

Lexeo Therapeutics Files $300 Million Mixed Shelf Registration

Paula H. Cholmondeley Bought 96% More Shares In Lexeo Therapeutics

Simply Wall St.

8 months ago

Paula H. Cholmondeley Bought 96% More Shares In Lexeo Therapeutics

Here's Why We're Watching Lexeo Therapeutics' (NASDAQ:LXEO) Cash Burn Situation

Simply Wall St.

8 months ago

Here's Why We're Watching Lexeo Therapeutics' (NASDAQ:LXEO) Cash Burn Situation

Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results

GlobeNewswire

9 months ago

Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results

MT Newswires

9 months ago

Lexeo Therapeutics Sees 'Positive' Interim Results for LX1001 to Treat APOE4-Linked Alzheimer's Disease

Lexeo Therapeutics Announces Positive Interim Data for LX1001, First-Ever Gene Therapy to Impact the Underlying Genetic Cause of APOE4-Associated Alzheimer’s Disease, at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference

GlobeNewswire

9 months ago

Lexeo Therapeutics Announces Positive Interim Data for LX1001, First-Ever Gene Therapy to Impact the Underlying Genetic Cause of APOE4-Associated Alzheimer’s Disease, at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Lexeo Therapeutics to Present New Interim Data from Phase 1/2 Trial of LX1001 at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Conference

GlobeNewswire

9 months ago

Lexeo Therapeutics to Present New Interim Data from Phase 1/2 Trial of LX1001 at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Conference

Lexeo Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Lexeo Therapeutics to Participate in Upcoming Investor Conferences

Lexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire

a year ago

Lexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights

Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates

Zacks

a year ago

Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates

Lexeo (LXEO) Down Despite Upbeat Rare Disease Gene Therapy Data

Zacks

a year ago

Lexeo (LXEO) Down Despite Upbeat Rare Disease Gene Therapy Data

Why Lexeo Therapeutics Collapsed 26%, Sacrificing A Breakout In Bearish Fashion

Investor's Business Daily

a year ago

Why Lexeo Therapeutics Collapsed 26%, Sacrificing A Breakout In Bearish Fashion

MT Newswires

a year ago

Sector Update: Health Care Stocks Retreat Monday Afternoon

MT Newswires

a year ago

Update: Lexeo Shares Tumble Despite 'Positive' Data in Trials of Gene Therapy Candidate for Cardiac Disorder

MT Newswires

a year ago

Lexeo Therapeutics Early Phase Trial for Friedreich Ataxia Cardiomyopathy Drug Shows Improvements in Cardiac Biomarkers

Lexeo gene therapy shows signs of heart benefit in small study

BioPharma Dive

a year ago

Lexeo gene therapy shows signs of heart benefit in small study

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy

GlobeNewswire

a year ago

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy

Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy on Monday, July 15, 2024

GlobeNewswire

a year ago

Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy on Monday, July 15, 2024

Lexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors

GlobeNewswire

a year ago

Lexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors

Companies Like Lexeo Therapeutics (NASDAQ:LXEO) Are In A Position To Invest In Growth

Simply Wall St.

a year ago

Companies Like Lexeo Therapeutics (NASDAQ:LXEO) Are In A Position To Invest In Growth

MT Newswires

a year ago

Baird Initiates Lexeo Therapeutics With Outperform Rating, $28 Price Target

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

MT Newswires

a year ago

HC Wainwright Initiates Lexeo Therapeutics at Buy With $22 Price Target

What Makes Lexeo Therapeutics, Inc. (LXEO) a New Buy Stock

Zacks

a year ago

What Makes Lexeo Therapeutics, Inc. (LXEO) a New Buy Stock

Wall Street Analysts Think Lexeo Therapeutics, Inc. (LXEO) Could Surge 57.82%: Read This Before Placing a Bet

Zacks

a year ago

Wall Street Analysts Think Lexeo Therapeutics, Inc. (LXEO) Could Surge 57.82%: Read This Before Placing a Bet

Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire

a year ago

Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights

Lexeo Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Lexeo Therapeutics to Participate in Upcoming Investor Conferences

Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy

GlobeNewswire

a year ago

Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy

Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy

GlobeNewswire

a year ago

Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy

Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing

GlobeNewswire

a year ago

Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

GlobeNewswire

a year ago

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing

GlobeNewswire

a year ago

Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing

Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments

GlobeNewswire

a year ago

Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments

Morningstar Research

a year ago

Analyst Report: Sinclair, Inc.

Sinclair Broadcast Group Names Jennifer Hansen Vice President/General Manager of WBMA/WABM and WTTO in Birmingham

Business Wire

a year ago

Sinclair Broadcast Group Names Jennifer Hansen Vice President/General Manager of WBMA/WABM and WTTO in Birmingham

Sinclair to Report Fourth Quarter 2023 Results on February 28, 2024 at 4:00 P.M. (Eastern Time)

Business Wire

a year ago

Sinclair to Report Fourth Quarter 2023 Results on February 28, 2024 at 4:00 P.M. (Eastern Time)

MarineMax, Inc. (NYSE:HZO) Q1 2024 Earnings Call Transcript

Insider Monkey

2 years ago

MarineMax, Inc. (NYSE:HZO) Q1 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Dime Community Bancshares Inc Earnings Call

Dime Community Bancshares Declares Quarterly Cash Dividend for Series A Preferred Stock

GlobeNewswire

2 years ago

Dime Community Bancshares Declares Quarterly Cash Dividend for Series A Preferred Stock

Dime Community (DCOM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

2 years ago

Dime Community (DCOM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Thomson Reuters StreetEvents

2 years ago

Q1 2024 MarineMax Inc Earnings Call

Nano Dimension Renews its Limited Duration Rights Plan

GlobeNewswire

2 years ago

Nano Dimension Renews its Limited Duration Rights Plan

Why MarineMax Shares Were Sinking Today

Motley Fool

2 years ago

Why MarineMax Shares Were Sinking Today

Lakeland Bancorp Inc (LBAI) Reports Decline in Net Income and Earnings Per Share for Q4 and ...

GuruFocus.com

2 years ago

Lakeland Bancorp Inc (LBAI) Reports Decline in Net Income and Earnings Per Share for Q4 and ...

Independent Bank Corporation Reports 2023 Fourth Quarter Results

GlobeNewswire

2 years ago

Independent Bank Corporation Reports 2023 Fourth Quarter Results

Should You Be Adding Navigator Holdings (NYSE:NVGS) To Your Watchlist Today?

Simply Wall St.

2 years ago

Should You Be Adding Navigator Holdings (NYSE:NVGS) To Your Watchlist Today?

The 7 Most Promising Flying Car Stocks According to Grok AI

InvestorPlace

2 years ago

The 7 Most Promising Flying Car Stocks According to Grok AI

Farmers National Banc Corp. Reports Year-End Growth Amidst Economic Challenges

GuruFocus.com

2 years ago

Farmers National Banc Corp. Reports Year-End Growth Amidst Economic Challenges

DISCO Announces C-Suite Elevations For Key Customer and People-Focused Roles

Business Wire

2 years ago

DISCO Announces C-Suite Elevations For Key Customer and People-Focused Roles

Aspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

PR Newswire

2 years ago

Aspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

4 Stocks to Watch From the Flourishing Water Supply Industry

Zacks

2 years ago

4 Stocks to Watch From the Flourishing Water Supply Industry

30 Most Underrated Cities in the US

Insider Monkey

2 years ago

30 Most Underrated Cities in the US

Saul Centers, Inc. Announces Tax Treatment of 2023 Dividends

PR Newswire

2 years ago

Saul Centers, Inc. Announces Tax Treatment of 2023 Dividends

Does Consolidated Water (NASDAQ:CWCO) Deserve A Spot On Your Watchlist?

Simply Wall St.

2 years ago

Does Consolidated Water (NASDAQ:CWCO) Deserve A Spot On Your Watchlist?

Snap One Launches Control4 Connect & Control4 Assist to Elevate the Customer Experience and Create New Recurring Revenue Opportunities for Partners

GlobeNewswire

2 years ago

Snap One Launches Control4 Connect & Control4 Assist to Elevate the Customer Experience and Create New Recurring Revenue Opportunities for Partners

Beazer Homes (BZH) Stock Moves -0.48%: What You Should Know

Zacks

2 years ago

Beazer Homes (BZH) Stock Moves -0.48%: What You Should Know

Associated Press Finance

2 years ago

Plexus, SunPower fall; Progress Software, Masonite International rise, Wednesday, 1/17/2024

Solar Stocks Are Having Another Bad Day. It’s More Than Just a Downgrade.

Barrons.com

2 years ago

Solar Stocks Are Having Another Bad Day. It’s More Than Just a Downgrade.

Optimistic Outlook for Offshore Drilling as E&P Capex Surge

Zacks

2 years ago

Optimistic Outlook for Offshore Drilling as E&P Capex Surge

Just Four Days Till Argan, Inc. (NYSE:AGX) Will Be Trading Ex-Dividend

Simply Wall St.

2 years ago

Just Four Days Till Argan, Inc. (NYSE:AGX) Will Be Trading Ex-Dividend

Eventbrite Introduces Instant Payouts and Tap to Pay, a Transformative Duo That Delivers a Win-Win Experience for Event Organizers and Attendees

Business Wire

2 years ago

Eventbrite Introduces Instant Payouts and Tap to Pay, a Transformative Duo That Delivers a Win-Win Experience for Event Organizers and Attendees

CLPMF: A Disruptive Service that Saves Time and Money for Businesses Depositing Cash and Replenishing Notes & Coins

Zacks Small Cap Research

2 years ago

CLPMF: A Disruptive Service that Saves Time and Money for Businesses Depositing Cash and Replenishing Notes & Coins

Saul Centers Inc's Dividend Analysis

GuruFocus.com

2 years ago

Saul Centers Inc's Dividend Analysis

MoneyLion Inc. (ML) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

2 years ago

MoneyLion Inc. (ML) Is a Great Choice for 'Trend' Investors, Here's Why

HCI Group to Redeem 4.25% Convertible Senior Notes

GlobeNewswire

2 years ago

HCI Group to Redeem 4.25% Convertible Senior Notes

Are Oils-Energy Stocks Lagging Enbridge (ENB) This Year?

Zacks

2 years ago

Are Oils-Energy Stocks Lagging Enbridge (ENB) This Year?

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes

GlobeNewswire

2 years ago

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes

Vital Farms Recognized as a 2024 Real Leaders®️ “Top Impact Company”

GlobeNewswire

2 years ago

Vital Farms Recognized as a 2024 Real Leaders®️ “Top Impact Company”

Radius Health, Inc. (NASDAQ:RDUS) Q1 2024 Earnings Call Transcript

Insider Monkey

2 years ago

Radius Health, Inc. (NASDAQ:RDUS) Q1 2024 Earnings Call Transcript

Investing in Arlo Technologies (NYSE:ARLO) a year ago would have delivered you a 143% gain

Simply Wall St.

2 years ago

Investing in Arlo Technologies (NYSE:ARLO) a year ago would have delivered you a 143% gain

15 Best Growth Stocks to Buy Under $25

Insider Monkey

2 years ago

15 Best Growth Stocks to Buy Under $25

Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 years ago

Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

WNS Recognized as a ‘Leader’ in Insurance by ISG

Business Wire

2 years ago

WNS Recognized as a ‘Leader’ in Insurance by ISG

FIGS, Inc.'s (NYSE:FIGS) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Simply Wall St.

2 years ago

FIGS, Inc.'s (NYSE:FIGS) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

With EPS Growth And More, Kimball Electronics (NASDAQ:KE) Makes An Interesting Case

Simply Wall St.

2 years ago

With EPS Growth And More, Kimball Electronics (NASDAQ:KE) Makes An Interesting Case

Share on Social Networks: